BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21520169)

  • 1. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma.
    Yoo BK; Santhekadur PK; Gredler R; Chen D; Emdad L; Bhutia S; Pannell L; Fisher PB; Sarkar D
    Hepatology; 2011 May; 53(5):1538-48. PubMed ID: 21520169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1 Protein) Promotes Hepatocarcinogenesis by Inhibiting Monoglyceride Lipase (MGLL).
    Rajasekaran D; Jariwala N; Mendoza RG; Robertson CL; Akiel MA; Dozmorov M; Fisher PB; Sarkar D
    J Biol Chem; 2016 May; 291(20):10736-46. PubMed ID: 26997225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AEG-1/MTDH/LYRIC in liver cancer.
    Sarkar D
    Adv Cancer Res; 2013; 120():193-221. PubMed ID: 23889992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The palmitoylation of AEG-1 dynamically modulates the progression of hepatocellular carcinoma.
    Zhou B; Wang Y; Zhang L; Shi X; Kong H; Zhang M; Liu Y; Shao X; Liu Z; Song H; Li W; Gao X; Chang Y; Dou C; Guo W; Zhang S; Kang X; Gao J; Liang Y; Zheng J; Kong E
    Theranostics; 2022; 12(16):6898-6914. PubMed ID: 36276642
    [No Abstract]   [Full Text] [Related]  

  • 5. Multifunction protein staphylococcal nuclease domain containing 1 (SND1) promotes tumor angiogenesis in human hepatocellular carcinoma through novel pathway that involves nuclear factor κB and miR-221.
    Santhekadur PK; Das SK; Gredler R; Chen D; Srivastava J; Robertson C; Baldwin AS; Fisher PB; Sarkar D
    J Biol Chem; 2012 Apr; 287(17):13952-8. PubMed ID: 22396537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma.
    Chen D; Yoo BK; Santhekadur PK; Gredler R; Bhutia SK; Das SK; Fuller C; Su ZZ; Fisher PB; Sarkar D
    Clin Cancer Res; 2011 Nov; 17(21):6693-701. PubMed ID: 21908579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of Nanoparticle-Delivered siRNA for Astrocyte Elevated Gene-1 (AEG-1) and All-trans Retinoic Acid (ATRA): An Effective Therapeutic Strategy for Hepatocellular Carcinoma (HCC).
    Rajasekaran D; Srivastava J; Ebeid K; Gredler R; Akiel M; Jariwala N; Robertson CL; Shen XN; Siddiq A; Fisher PB; Salem AK; Sarkar D
    Bioconjug Chem; 2015 Aug; 26(8):1651-61. PubMed ID: 26079152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astrocyte Elevated Gene-1 (AEG-1) Contributes to Non-thyroidal Illness Syndrome (NTIS) Associated with Hepatocellular Carcinoma (HCC).
    Srivastava J; Robertson CL; Gredler R; Siddiq A; Rajasekaran D; Akiel MA; Emdad L; Mas V; Mukhopadhyay ND; Fisher PB; Sarkar D
    J Biol Chem; 2015 Jun; 290(25):15549-15558. PubMed ID: 25944909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
    Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
    Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocyte elevated gene-1 promotes hepatocarcinogenesis: novel insights from a mouse model.
    Srivastava J; Siddiq A; Emdad L; Santhekadur PK; Chen D; Gredler R; Shen XN; Robertson CL; Dumur CI; Hylemon PB; Mukhopadhyay ND; Bhere D; Shah K; Ahmad R; Giashuddin S; Stafflinger J; Subler MA; Windle JJ; Fisher PB; Sarkar D
    Hepatology; 2012 Nov; 56(5):1782-91. PubMed ID: 22689379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranscriptional Inhibition of Protein Tyrosine Phosphatase Nonreceptor Type 23 by Staphylococcal Nuclease and Tudor Domain Containing 1: Implications for Hepatocellular Carcinoma.
    Jariwala N; Mendoza RG; Garcia D; Lai Z; Subler MA; Windle JJ; Mukhopadhyay ND; Fisher PB; Chen Y; Sarkar D
    Hepatol Commun; 2019 Sep; 3(9):1258-1270. PubMed ID: 31497746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanism of chemoresistance by astrocyte elevated gene-1.
    Yoo BK; Chen D; Su ZZ; Gredler R; Yoo J; Shah K; Fisher PB; Sarkar D
    Cancer Res; 2010 Apr; 70(8):3249-58. PubMed ID: 20388796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma.
    Cui X; Zhao C; Yao X; Qian B; Su C; Ren Y; Yao Z; Gao X; Yang J
    RNA Biol; 2018; 15(10):1364-1375. PubMed ID: 30321081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocyte elevated gene-1 (AEG-1): A key driver of hepatocellular carcinoma (HCC).
    Banerjee I; Fisher PB; Sarkar D
    Adv Cancer Res; 2021; 152():329-381. PubMed ID: 34353442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis.
    Tsuchiya N; Ochiai M; Nakashima K; Ubagai T; Sugimura T; Nakagama H
    Cancer Res; 2007 Oct; 67(19):9568-76. PubMed ID: 17909068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astrocyte Elevated Gene-1 Regulates Macrophage Activation in Hepatocellular Carcinogenesis.
    Robertson CL; Mendoza RG; Jariwala N; Dozmorov M; Mukhopadhyay ND; Subler MA; Windle JJ; Lai Z; Fisher PB; Ghosh S; Sarkar D
    Cancer Res; 2018 Nov; 78(22):6436-6446. PubMed ID: 30181179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocyte elevated gene-1 and c-Myc cooperate to promote hepatocarcinogenesis in mice.
    Srivastava J; Siddiq A; Gredler R; Shen XN; Rajasekaran D; Robertson CL; Subler MA; Windle JJ; Dumur CI; Mukhopadhyay ND; Garcia D; Lai Z; Chen Y; Balaji U; Fisher PB; Sarkar D
    Hepatology; 2015 Mar; 61(3):915-29. PubMed ID: 25065684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staphylococcal nuclease domain containing-1 (SND1) promotes migration and invasion via angiotensin II type 1 receptor (AT1R) and TGFβ signaling.
    Santhekadur PK; Akiel M; Emdad L; Gredler R; Srivastava J; Rajasekaran D; Robertson CL; Mukhopadhyay ND; Fisher PB; Sarkar D
    FEBS Open Bio; 2014; 4():353-61. PubMed ID: 24918049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of the methylarginine reader function of SND1 confers resistance to hepatocellular carcinoma.
    Wright T; Wang Y; Stratton SA; Sebastian M; Liu B; Johnson DG; Bedford MT
    Biochem J; 2023 Nov; 480(22):1805-1816. PubMed ID: 37905668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma.
    Jariwala N; Rajasekaran D; Mendoza RG; Shen XN; Siddiq A; Akiel MA; Robertson CL; Subler MA; Windle JJ; Fisher PB; Sanyal AJ; Sarkar D
    Cancer Res; 2017 Jun; 77(12):3306-3316. PubMed ID: 28428278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.